DrugDashboards

Market view

dobutamine · Injection

2 marketed package NDCs · 1 active manufacturer

The short version

Only one company currently supplies this market — there is no backup if it stumbles. It is in shortage right now.

Same drug class

Other molecules FDA puts in beta-Adrenergic Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Dobutamine in shortage right now?
Yes. FDA currently lists Dobutamine in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Dobutamine?
4 companies have marketed Dobutamine in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage nowDobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)Nov 6, 2017

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.